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Introduction 
Each time a medical marijuana patient drives in Ohio, the patient 
may be illegally operating a vehicle while under the influence of 
marijuana (marijuana OVI). It is not a novel idea that a patient 
actually impaired by medical marijuana should not be driving, but the 
Ohio marijuana OVI law criminalizes driving with a certain amount of 
marijuana detectable in a driver’s bodily fluids.1 Ohio may charge a 
patient with a marijuana OVI without proof beyond a reasonable doubt 
of actual impairment. Instead, a patient’s blood or urine test that is 
positive for a prohibited amount of marijuana satisfies the crime of a 
marijuana OVI in Ohio. The issue is that the prohibited amount of 
marijuana detected in blood or urine does not correlate with actual 
impairment.2 Marijuana detected in patients’ blood or urine does not 
indicate that those patients really are driving impaired. 
This Note incrementally explains the risks behind the wheel for 
patients enrolled in the Ohio Medical Marijuana Control Program3 
(OMMCP) and the challenges that all parties involved must solve for 
patients to drive safely without fear of unjust punishment. 
This Note begins with the basics of marijuana, how marijuana 
affects driving, and the difficulties testing for marijuana impairment. 
Second, this Note briefly explains rational basis scrutiny and then 
applies it to the Ohio marijuana OVI law. Third, this Note addresses 
the relevant parts of the OMMCP laws that facilitate the medical 
marijuana product and information about the product to the patient. 
Then, the fourth Part of this Note opines that the Ohio marijuana OVI 
law wrongly captures medical marijuana patients who have marijuana 
in their body but are unimpaired. Lastly, this Note argues that a 
 
1. See Ohio Rev. Code § 4511.19(A)(1)(a) (2019) (“No person shall operate 
any vehicle, streetcar, or trackless trolley within this state, if, at the time 
of the operation, . . . the person is under the influence of alcohol, a drug of 
abuse, or a combination of them.”); see also Ohio Rev. Code 
§ 4511.19(A)(1)(j)(vii) (2019) (“No person shall operate any vehicle, street–
car, or trackless trolley within this state, if, at the time of the operation, 
. . . the person has a concentration of marihuana in the person’s urine of at 
least ten nanograms of marihuana per milliliter of the person’s urine or has 
a concentration of marihuana in the person’s whole blood or blood serum 
or plasma of at least two nanograms of marihuana per milliliter of the 
person’s whole blood or blood serum or plasma.”). 
2. See Richard P. Compton, U.S. Dep’t of Transp., DOT HS 812 440, 
Marijuana-Impaired Driving: A Report to Congress 13–16, 27 (July 
2017), http://www.nhtsa.gov/Driving%20Safety/Research%20&%20Eval 
uation [https://perma.cc/72BQ-LLFD] [hereinafter NHTSA Report]. 
3. See Ohio’s Office Resource for the Medical Marijuana Control Program, 
Ohio Med. Marijuana Control Program, https://www.medical 
marijuana.ohio.gov/ [https://perma.cc/BF4D-49P3] (last visited Mar. 19, 
2020). 
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permissible-inference law is fairer and more scientifically valid than a 
per se law for marijuana OVIs and recommends actions for parties 
involved in the OMMCP and law enforcement. 
I. Marijuana and Driving 
A. Marijuana 
Marijuana is a psychoactive drug derived from the leaves and 
flowers of the Cannabis sativa plant.4 Delta-9-tetrahydrocannabinol 
(THC) is the chemical in marijuana most responsible for psychoactive 
effects.5 Common effects of THC include relaxation and pleasant 
experiences, though users might also suffer unpleasant experiences of 
anxiety, schizophrenia, fear, or panic.6 
Health organizations consistently warn that THC has a short-term 
effect on impairing attention, memory, spatial orientation, and 
learning.7 Cannabidiol (CBD), another dominant chemical found in 
cannabis, lacks the impairing characteristics of THC.8 
“Medical marijuana” refers to marijuana used with the intent of 
treating symptoms and conditions of illness.9 Medical marijuana is 
derived from a variety of cannabis plants, compounded into a non-stan–
dardized dose, and presented through both smoking and non-smoking 
forms for consumption.10 There is substantial evidence that medical 
marijuana has therapeutic benefits for the treatment of chronic pain in 
adults, nausea and vomiting after chemotherapy, and muscle spasticity 
 
4. Drug Facts: Marijuana, U.S. Drug Enf’t Admin., https://www.dea.gov/ 
factsheets/marijuana [https://perma.cc/FW5Q-7AJL] (last visited Jan. 3, 
2020). 
5. Jon O. Ebbert, Eugene L. Scharf & Ryan T. Hurt, Medical Cannabis, 93 
Mayo Clinic Proc. 1842, 1844 (2018). 
6. Drug Facts: Marijuana, Nat’l Inst. On Drug Abuse 6 (Dec. 2019), 
https://www.drugabuse.gov/sites/default/files/drugfacts-marijuana.pdf 
[https://perma.cc/7R56-R3P8]. 
7. See Ebbert et al., supra note 5, at 1844; see also Marijuana: How Can It 
Affect Your Health?, Ctrs. for Disease Control & Prevention (Feb. 
27, 2018), https://www.cdc.gov/marijuana/health-effects.html [https://per 
ma.cc/D4AD-ECRJ] (providing an overview of the impact of marijuana use 
on various types of physical health). 
8. Ebbert et al., supra note 5, at 1844. 
9. Id. at 1842–43. But Mayo Clinic physicians warn their peers that 
“conclusive or substantial evidence suggesting that cannabis is effective for 
the treatment of any medical condition does not presently exist and instead 
suggests that it may be effective for symptom control only.” Id. at 1845. 
10. Ebbert et al., supra note 5, at 1842. While some states allow patients to 
smoke medical marijuana, Ohio law prohibits the “smoking or combustion 
of medical marijuana.” Ohio Rev. Code § 3796.06(B)(1). 
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in patients with multiple sclerosis.11 The FDA approved synthetic THC-
active pills, dronabinol and nabilone, to treat chemotherapy-induced 
nausea and vomiting and to improve appetite for AIDS patients, and 
the FDA recently approved a CBD-active liquid, Epidolex, to treat 
childhood seizure and epilepsy.12 The FDA has approved only these 
specific drugs,13 and the types of medical marijuana this Note later 
discusses are not approved by the FDA. 
B. Marijuana’s Effects on Driving 
Medical marijuana can impair safe driving skills.14 Judgment, motor 
coordination, and reaction time are major driving skills that THC 
significantly impairs.15 One of the most consistent manifestations of 
marijuana impairment on the road is that drivers under the influence 
of marijuana tend to sway into other lanes.16 For example, drivers are 
likely to engage in “lane weaving, driving on the wrong side of the road, 
 
11. Robert A. Gilchick, Am. Med. Ass’n Council on Sci. and Pub. 
Health, Rep. No. 5-I-7, Clinical Implications and Policy Consid–
erations of Cannabis Use 5 (2017), https://www.aapmr.org/docs/ 
default-source/advocacy/ama-hod/ama-council-on-science-and-public-health 
-(csph)-report-on-the-clinical-implications-and-policy-considerations-of-cann 
abis-use.pdf [https://perma.cc/ZHQ7-FNFQ] [hereinafter AMA Report]. 
12. Steven A. King, Cannabinoids and Pain, Psychiatric Times (Feb. 1, 2008), 
https://www.psychiatrictimes.com/view/cannabinoids-and-pain [https:// 
perma.cc/5YHJ-ZBLA]; FDA Approves First Drug Comprised of an Active 
Ingredient Derived from Marijuana to Treat Rare, Severe Forms of 
Epilepsy, FDA, https://www.fda.gov/news-events/press-announcements/ 
fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-trea 
t-rare-severe-forms [https://perma.cc/LEZ4-LVNY] (last updated Mar. 27, 
2020). 
13. FDA Regulation of Cannabis and Cannabis-Derived Products: Questions 
and Answers, FDA, https://www.fda.gov/news-events/public-health-focus 
/fda-regulation-cannabis-and-cannabis-derived-products-questions-and-ans 
wers#othercbdapproved [https://perma.cc/D2HK-EGGY] (last updated 
Jan. 22, 2021). 
14. Marijuana and Public Health: Driving and Car Crashes, Ctrs. for 
Disease Control & Prevention, https://www.cdc.gov/marijuana/ 
nas/driving.html [https://perma.cc/27PQ-L7GE] (last updated Feb. 26, 
2018). 





16. See R. Andrew Sewell, James Poling & Mehmet Sofuoglu, The Effect of 
Cannabis Compared with Alcohol on Driving, 18 Am. J. on Addictions 
185, 186–87 (2009); see also Mary A. Celeste, The Impact of the Gerhardt 
Decision on Marijuana Driving Cases, 53 Ct. Rev. 170, 171 (2017); AMA 
Report, supra note 11, at 8. 
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drifting, following too close, driving a large distance from the vehicle 
ahead, [and] not responding to questions.”17 In an experimental study, 
drivers under the influence of marijuana adopted strategies to 
compensate for their perceived level of impairment.18 Likewise, the 
American Medical Association found that drivers under the influence of 
marijuana drove slower and under the speed limit more frequently than 
those not under the influence of marijuana, and drove with greater 
space between the preceding vehicle.19 The studies, mostly controlled, 
illuminate how marijuana affects driving—but the question presented 
is how can law enforcement actively test for marijuana impairment on 
the road? 
C. Problems with Testing for Marijuana Impairment 
The key problem with testing for marijuana impairment is the lack 
of technology that can detect THC impairment and the lack of a 
scientifically agreed-upon level of THC that could cause impairment.20 
Drivers’ level of detectable THC does not correlate with their extent, if 
any, of impairment.21 Quite notably, people may not show symptoms of 
impairment when their THC levels are high, and may actually show 
symptoms of impairment when their THC levels are low.22 If a driver 
consumes marijuana frequently, such as when a patient consumes daily 
medicinal doses, law enforcement may detect THC one week after 
 
17. Celeste, supra note 16, at 171 (citing Edward M. Kosinski, Robert L. 
Yolton, Karl Citek, Charles E. Hayes & Richard B. Evans, The Drug 
Evaluation Classification Program: Using Ocular and Other Signs to Detect 
Drug Intoxication, 69 J. Am. Optometric Ass’n 211, 213 (1998)). 
18. See Sewell et al., supra note 16, at 186. 
19. AMA Report, supra note 11, at 8. 
20. Drugged Driving: Marijuana-Impaired Driving, Nat’l Conf. of State 
Legislatures (Nov. 9, 2020), https://www.ncsl.org/research/transpor 
tation/drugged-driving-overview.aspx [https://perma.cc/6S28-3ZXV]. 
21. See, e.g., Sewell et al., supra note 16, at 187 (“Meta-analyses of over 120 
studies have found that in general, the higher the estimated concentration 
of THC in blood, the greater the driving impairment, but that more 
frequent users of marijuana show less impairment than infrequent users at 
the same dose, either because of physiological tolerance or learned compen–
satory behavior. Maximal impairment is found 20 to 40 minutes after 
smoking, but the impairment has vanished 2.5 hours later, at least in those 
who smoke 18 mg THC or less (the dose often used experimentally to 
duplicate a single joint).”). 
22. AMA Report, supra note 11, at 8. 
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consumption.23 Therefore, even if there is a great accumulation of THC 
in a driver’s body, the driver may actually be driving unimpaired.24 
In Commonwealth v. Gerhardt,25 the Massachusetts Supreme Court 
decided that police cannot conclude that a driver is impaired from 
marijuana after the driver’s poor performance on a field sobriety test 
(FST).26 The court held, however, that the driver’s performance on an 
FST is an observation that is admissible evidence for determining if the 
driver was impaired.27 In that case, Thomas Gerhardt was pulled over 
because his vehicle’s rear lights were off. The officer subsequently 
smelled marijuana burning.28 Gerhardt admitted to the officer that he 
smoked about one gram of marijuana three hours earlier.29 The officer 
then asked Gerhardt to exit his vehicle and instructed him to complete 
three FSTs: the horizontal gaze nystagmus test, the nine-step walk-
and-turn test (WAT), and the one-leg-stand test (OLS).30 Gerhardt 
failed the WAT and OLS, both tests of “an individual’s balance, 
coordination, dexterity, ability to follow directions, and ability to focus 
attention on multiple subjects at the same time.”31 The court held that 
Gerhardt’s failure on the WAT and OLS was admissible evidence 
because the skills the two tests assess are skills that are necessary for 
safe driving.32 FSTs, therefore, are valid tests for officers to employ 
when they have a suspicion that a driver is under the influence of 
marijuana because the tests are designed to determine if a person has 
the ability to drive safely, not if a person is actually under the influence 
of marijuana.33 Unlike the proven correlation between FSTs and alcohol 
impairment, FSTs do not have a proven correlation with marijuana-
intoxication levels that cause impairment.34 
 
23. See Matthew Berger, Why it’s Difficult to Develop a Roadside Test for 
Marijuana, Healthline (Sept. 24, 2018), https://www.healthline.com/ 
health-news/difficult-to-develop-roadside-test-for-marijuana [https://perm 
a.cc/8XRC-9SEB]. 
24. Drugged Driving: Marijuana-Impaired Driving, supra note 20. 
25. 81 N.E.3d 751 (Mass. 2017). 
26. Id. at 754. 
27. Id. 
28. Id. at 755. 
29. Id. 
30. Id. at 755–56. 
31. Id. at 756. 
32. Id. at 759. 
33. Id. at 760. 
34. Id. at 754. 
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The correlation that allows law enforcement to determine if a driver 
is too impaired by alcohol to drive safely is the result of a long scientific 
history of developing a standard of impairment of alcohol, a standard 
that is not yet developed for impairment of marijuana.35 The 
inebriation-inducing properties of alcohol were well-understood and 
legitimized by systemic case-control studies.36 A per se standard of 
impairment for alcohol was possible because there was a nationally 
recognized level of alcohol in a driver’s body that correlated with an 
increased crash risk.37 
The alcohol model of developing a standard of impairment is not 
informative for developing laws for marijuana-impaired driving because 
there is not a significant relationship between THC levels in a driver’s 
body and an increased crash risk.38 For an impairment law that 
conditions criminality on the amount of a drug in a driver’s body to be 
valid, there must be a scientifically understood level of the drug in a 
driver’s body that causes impaired driving.39 Research has not yet 
established a relationship between a specific THC level and impair–
ment.40 
Additionally, the underlying method of determining alcohol 
impairment is inconsistent with marijuana impairment because alcohol 
and THC molecules function very differently.41 In terms of solubility, 
alcohol is small and water-soluble while THC is large and fat-soluble.42 
Therefore, alcohol molecules transverse the blood-brain barrier much 
faster than THC molecules and create an equilibrium of alcohol 
molecules in a person’s blood and their brain.43 On the other hand, THC 
 
35. See Ed Wood, Why a 5 ng/ml Limit is Bad Public Policy—and the Case 
For Tandem per se DUID Legislation, 10 J. Glob. Drug Pol’y & Prac. 
1, 2–4 (2016). 
36. Id. at 2.  
37. Id. at 2, 14–15.  
38. See Michael McWaters, The High Road: An Analysis of Marijuana as an 
Impairing Substance and Why Marijuana Laws Fail to Adhere to the 
Framework of DUI Alcohol Legislation, 1 U. Cent. Fla. Dep’t Legal 
Stud. L.J. 51, 57–58 (2018) (arguing that the use of the alcohol 
methodology of determining impairment is opposite from the kind of 
methodology that should be used for determining marijuana impairment 
because there is no correlation found in marijuana epidemiological studies 
like the studies of alcohol in which amount and time of alcohol consum–
ption, BAC, and accident risk all correlate). 
39. See Wood, supra note 35, at 16. 
40. See NHTSA Report, supra note 2, at 11. 
41. See Wood, supra note 35, at 4. 
42. Id.  
43. Id.  
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molecules transverse the blood-brain barrier much slower. Instead, THC 
molecules diffuse into fatty tissue, such as a person’s heart, lungs, and 
brain where the THC molecules are active beyond the time frame when 
marijuana may be detectable in blood.44 
Marijuana and alcohol also differently affect drivers’ behavior. Most 
importantly, the behavioral effects of marijuana vary by individual and 
their tolerance and consumption method, while the effects of alcohol 
are more uniform and predictable across individuals.45 Marijuana affects 
automatic functions more than cognitive functions, but alcohol affects 
cognitive functions more than automatic functions.46 The difference in 
how the molecules react in drivers’ bodies and affect behavior is why it 
is challenging, if not faulty, to apply alcohol-impairment testing metho–
dology to marijuana-impairment testing.47 
Despite the complex and individualized relationship between THC 
and impairment, healthcare companies, technology start-ups, and 
universities are creating devices for law enforcement to easily detect the 
presence of THC in a driver’s body.48 A front-runner in manufacturing 
a THC breathalyzer is Hound Labs. The Hound Marijuana Breathalyzer 
detects marijuana consumption within two to three hours of use, and 
the company asserts that the breathalyzer is not measuring impairment 
but “objective data” about recent marijuana use.49 
Because a chemical test alone cannot prove impairment, interested 
parties argue that a driver must exhibit other evidence of impairment 
in order to support a valid determination that an individual is unsafely 
driving under the influence of marijuana.50 The National Highway 
Traffic Safety Administration (NHTSA) disclosed in 2017 that tests 
other than chemical tests are necessary to test for marijuana 
impairment, but “available research does not support the development 
of such a psychomotor, behavioral or cognitive test that would be 
 
44. See id. 
45. Sewell et al., supra note 16, at 190. 
46. Id. at 187. 
47. See Berger, supra note 23. 
48. Alicia Wallace, Testing Drivers for Cannabis is Hard. Here’s Why, CNN: 
Bus. (Jan. 2, 2020, 4:50 PM), https://www.cnn.com/2020/01/02/business/ 
cannabis-breathalyzers-are-coming-to-market/index.html [https://perma.c 
c/4AA9-XS46].  
49. Id. (“‘We aren’t measuring impairment, we’re measuring THC in breath 
where it lasts a very short period of time, providing objective data about 
THC in breath to law enforcement and employers to use in conjunction 
with other information they have gathered,’ said Hound Labs founder Mike 
Lynn . . . .”). 
50. See McWaters, supra note 38, at 67–68; see also NHTSA Report, supra 
note 2, at 13. 
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practical and feasible for law enforcement use at this time.”51 
Alternative tests, like the FSTs used in Gerhardt,52 may be able to 
determine impairment, but the tests may not determine that the 
impairment was caused by marijuana instead of other factors like a 
driver’s emotional state, intelligence, or drowsiness.53 
II. Rationality of Ohio Marijuana OVI Law 
Drivers should not be subject to arbitrary state driving laws. Laws 
that infringe on non-fundamental rights, such as driving laws, must be 
only rational under current constitutional doctrine. This section 
explains rational basis review and the Ohio marijuana OVI law. If 
challenged, a court would likely defer to the Ohio General Assembly 
and find the law constitutional because the marijuana OVI law is one 
rational means to prevent drivers who are impaired by marijuana from 
driving, regardless of better alternatives. 
A. Rational Basis Standard 
The Fourteenth Amendment provides: “No State shall . . . deprive 
any person of life, liberty, or property without due process of law.”54 In 
the marijuana OVI law context, the issue is substantive due process, 
which demands a certain degree of justification for a law that infringes 
life, liberty, or property.55 The extent of the justification for a law 
depends on the nature of the right infringed upon.56 If the law limits a 
non-fundamental right, such as driving, then rational basis scrutiny 
applies and demands that the law be reasonably related to a legitimate 
government interest, such as roadway safety.57 
It is relatively easy for a law to meet the minimal standard of mere 
rationality. If a court reviews a state law using rational basis scrutiny, 
the court will decide that a law is rational if the law is targeted at a 
legitimate state interest and the state legislature could have thought 
that the law was a rational way to address that interest.58 The court 
 
51. NHTSA Report, supra note 2, at 13. 
52. Commonwealth v. Gerhardt, 81 N.E.3d 751, 755–56 (Mass. 2017). 
53. NHTSA Report, supra note 2, at 12. 
54. U.S. Const. amend. XIV, § 1. 
55. Meyer v. Nebraska, 262 U.S. 390, 399–400 (1923). 
56. See, e.g., San Antonio Indep. Sch. Dist. v. Rodriguez, 411 U.S. 1, 16–17 
(1973). 
57. See, e.g., Williamson v. Lee Optical, 348 U.S. 483 (1954).  
58. Id. at 488 (“It is enough that there is an evil at hand for correction, and 
that it might be thought that the particular legislative measure was a ra–
tional way to correct it.”). 
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will not consider if the state legislated wisely in determining if the law 
is rational because of the separation of powers.59 Therefore, even if the 
court would weigh the facts and interests underlying the law differently 
than the legislature, the legislature’s decision satisfies substantive due 
process under rational basis scrutiny so long as the court finds that the 
legislature’s decision might be a rational way to meet the state’s 
interest.60 
B. Ohio Marijuana OVI Law 
Ohio charges drivers with “Operating a Vehicle while under the 
Influence” (OVI) who test positive for marijuana or marijuana metab–
olite according to the amount of nanograms per milliliter (ng/mL) in a 
driver’s urine, whole blood, blood serum, or plasma.61 Ohio’s law is 
categorized as a “per se” law because if a driver tests positive for a 
particular amount of marijuana or marijuana metabolite, then the 
driver drove under the influence of marijuana.62 A driver may face 
criminal penalty when testing positive for (1) 10 ng/mL in urine or 
2ng/mL in blood for marijuana;63 (2) 35 ng/mL in urine or 50 ng/mL 
in blood for marijuana metabolite;64 or (3) 15ng/mL in urine or 5 ng/mL 
in blood for marijuana metabolite combined with alcohol or another 
drug of abuse.65 A driver who tests positive may be incarcerated, 
ordered to participate in Ohio’s Drug Intervention Program, fined, 
suspended from driving, and ordered to change to license plates 
denoting that the driver has been charged with a marijuana OVI.66 
C. Rational Basis Scrutiny and Ohio Marijuana OVI Law 
In order for Ohio’s marijuana OVI law to satisfy rational basis 
scrutiny, a court must find that the law is a rational means to achieve 
a legitimate governmental interest. A court would likely defer to the 
decision of the Ohio legislature to enact a per se law of impairment, 
even in light of its tenuous grounding in science.67 
 
59. See U.S. v. Carolene Prods. Co., 304 U.S. 144, 154 (1937). 
60. See Williamson, 348 U.S. at 487–88 (1954). 
61. Ohio Rev. Code § 4511.19(A)(1)(j)(vii) (2019). 
62. See Charles R. Cordova, Jr., DWI and Drugs: A Look at Per Se Laws for 
Marijuana, 7 Nev. L.J. 570, 570 n.1 (2007). 
63. Ohio Rev. Code § 4511.19(A)(1)(j)(vii). 
64. Id. § 4511.19(A) (1) (j)(viii)(II) (2019). 
65. Id. § 4511.19(A)(1)(j)(viii)(I) (2019). 
66. Id. § 4511.19(G)(1)–(3) (2019). 
67. Other state courts have found that marijuana OVI laws satisfy rational basis 
scrutiny for substantive due process. See, e.g., Williams v. State, 50 P.3d 
1116, 1120, 1122 (Nev. 2002) (rejecting the plaintiff’s argument that the state 
should not prosecute unimpaired drivers for low levels of marijuana because 
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First, Ohio has a legitimate state interest that the marijuana OVI 
law targets. Public health and safety are within the police power of any 
state,68 and Ohio’s interest in maintaining safe roads is a legitimate 
state interest.69 
Second, Ohio’s marijuana OVI law likely satisfies the minimal 
constitutional requirement that it be a rational means of maintaining 
safe roads. There is a rational connection in demanding that an 
individual who has consumed a drug that negatively influences safe-
driving skills not be allowed to drive so as to protect that individual’s 
and others’ safety. Additionally, a per se law like Ohio’s has a deterrent 
effect that benefits roadway safety: per se laws reduce the likelihood of 
drivers testing positive for marijuana.70 On the other hand, there is not 
a rational connection in penalizing individuals driving with a state-
prohibited amount of marijuana in their bodily fluids when the state-
prohibited amount is not an accurate measure of risk to roadway safety. 
Ohio’s law suffers from a lack of scientific validation. While the 
Ohio marijuana OVI law may pass constitutional muster, it does not 
satisfy scientific legitimacy. In order for Ohio’s per se law of impairment 
to be scientifically valid, the established ng/mL levels of marijuana in 
the Ohio Revised Code must be shown to define unsafe impairment.71 
There is little evidence to support the scientific validity of per se limits 
for marijuana.72 Specifically, research does not consistently show a 
meaningful level between a testable amount of marijuana in a person’s 
urine or blood and impairment.73 A person testing positive for a high 
amount of THC can be minimally impaired; likewise, a person testing 
positive for a low amount of THC can be highly impaired.74 
 
the legislature could have had at least one plausible ground for enacting the 
marijuana OVI law, and the marijuana OVI law is constitutional regardless 
of if the law is an “imperfect fit” between the behavior it criminalizes and 
the goal of roadway safety sought); People v. Rennie, 10 N.E.3d 994, 998 
(Ill. App. Ct. 2014). 
68. Metro. Life Ins. Co. v. Mass., 471 U.S. 724, 756 (1985). 
69. See Cindy Antrican, Drugged Driving Has Become Too Common; Safety 
Tips, Dayton Daily News (June 1, 2017), https://www.daytondaily 
news.com/news/local/drugged-driving-has-become-too-common-safety-tips/ 
LTvUQniygxnbH4Kmg35o8N/ [https://perma.cc/76GF-2XUC]. 
70. Eric L. Sevigny, The Effects of Medical Marijuana Laws on Cannabis-
Involved Driving, 118 Accident Analysis & Prevention 57, 64 (2018). 
71. See McWaters, supra note 38, at 57–58 (“For these laws to be validly 
enforced, however, it must be scientifically demonstrated that a measurable 
quantity of the drug in an individuals’ body causes criminal impairment.”). 
72. AMA Report, supra note 11, at 10. 
73. NHTSA Report, supra note 2, at 11. 
74. AMA Report, supra note 11, at 8. 
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Statutory limits on marijuana in a driver’s bodily system do not 
reflect impairment. The NHTSA criticized Ohio and Nevada’s per se 
laws set at 2 ng/mL for marijuana in blood. The NHTSA reported that 
24.2% of drivers who were suspected of marijuana-impaired driving by 
drug recognition experts or other arresting officers had less 
than 2 ng/mL of marijuana in their blood.75 Almost a quarter of drivers 
who presented symptoms or other evidence of impairment from mari–
juana were not caught by the threshold set in the Ohio marijuana OVI 
law.76 The source of this discrepancy is likely because of the timing of 
use and testing. If marijuana use occurred on the day of a traffic 
violation, “because THC can spike and leave the bloodstream in less 
than three hours—despite impairment potentially lasting six to eight 
hours—a blood test taken an hour or more after a traffic stop may fail 
to identify impairment due to marijuana use.”77 And if marijuana use 
occurred prior to the day of a traffic violation, a person may still test 
positive for the established levels of marijuana because THC may 
remain in the body for days and possibly weeks.78 
The lack of relationship between Ohio’s proscribed THC level that 
constitutes impaired driving and that required to produce actual 
impairment indicates that Ohio’s per se law is invalid in the eyes of 
science, though it may nevertheless satisfy rational basis scrutiny in the 
eyes of the law. The remainder of the Note illustrates why per se laws 
for marijuana impairment, like Ohio’s, are particularly troublesome for 
medical marijuana patients. 
III. Medical Marijuana in Ohio 
A. Medical Marijuana Products 
The medical marijuana available through state medical marijuana 
programs is not an FDA-approved medicine and does not satisfy federal 
requirements that a drug’s benefits be shown to outweigh its risks to 
receive the “medical” label.79 Unlike FDA-approved medicines, medical 
marijuana’s purity, potency, safety, quality, and effectiveness may vary 
widely.80 The FDA has sent warning letters to medical marijuana 
 
75. NHTSA Report, supra note 2, at 28–29. 
76. Id. 
77. See Berger, supra note 23. 
78. NHTSA Report, supra note 2, at 4–5. 
79. FDA and Cannabis: Research and Drug Approval Process, FDA, 
https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-
research-and-drug-approval-process [https://perma.cc/S9W8-WLB6] (last 
updated Oct. 1, 2020).  
80. Id. 
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companies that advertise marijuana products as a medicine with 
therapeutic benefits because labeling a drug as a medicine without 
obtaining FDA approval violates federal law and puts patients at risk.81 
While the FDA encourages states to research and develop safe and 
effective marijuana products, the FDA maintains the position that 
marijuana is not scientifically proven to treat illness.82 The word 
“medical” in state “medical marijuana” programs is thus deceptive 
because marijuana is not an FDA-approved medicine. To the contrary, 
the federal government labels marijuana as a drug with no acceptable 
medical use.83 
B. Ohio Medical Marijuana Control Program 
On September 8, 2016, the 131st Ohio General Assembly passed 
House Bill 523 to authorize the use of marijuana for medical purposes,84 
enabling Ohio to create a pathway for patients with any of twenty-one 
qualifying medical conditions to receive medical marijuana.85 Ohio reg–
ulates the licensed entities—cultivators, processors, testing laboratories, 
dispensaries, and physicians—involved in the OMMCP, including by 
requiring testing and labeling throughout the transactions.86 Every step 
of the distribution chain contributes to ultimately inform the end 
 
81. FDA Regulation of Cannabis and Cannabis-Derived Products, supra note 
13. 
82. FDA and Cannabis: Research and Drug Approval Process, supra note 79. 
83. See Controlled Substances Act, 21 U.S.C. § 812(b) (2018) (describing 
Schedule I substances as including those with no currently accepted 
medical use in the US); see also Drug Scheduling, U.S. Drug Enf’t 
Admin., https://www.dea.gov/drug-scheduling [https://perma.cc/6JZU-
DZU5] (last visited Mar. 29, 2021). 
84. See House Bill 523, Ohio Legislature, https://www.legislature.ohio. 
gov/legislation/legislation-summary?id=GA131-HB-523 [https://perma. 
cc/LB8Y-SP5W] (last visited Mar. 29, 2021). 
85. Ohio Rev. Code § 3796.01(A)(6) (2019) (listing acquired immune 
deficiency syndrome, Alzheimer’s disease, amyotrophic lateral sclerosis, 
cancer, chronic traumatic encephalopathy, Crohn’s disease, epilepsy or 
another seizure disorder, fibromyalgia, glaucoma, hepatitis C, inflammatory 
bowel disease, multiple sclerosis, pain that is chronic or severe or pain that 
is intractable, Parkinson’s disease, positive HIV status, post-traumatic 
stress disorder, sickle cell anemia, spinal cord disease or injury, Tourette’s 
syndrome, traumatic brain injury, and ulcerative colitis each as a “quali–
fying medical condition”). 
86. See generally id. ch. 3796 (2019) (including sections regulating number of 
cultivator licenses, licenses for processing or testing medical marijuana, 
dispensary licenses, and caregiver rights); Ohio Dep’t of Com. Med. 
Marijuana Control Program, Product Packaging and Labeling 
Guidance (May 2019). 
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consumer, the patient, about the potency and risks of medical 
marijuana. 
Cultivators are the first party in the distribution chain, and they 
are the first party charged with documenting the variable contents in 
each batch of marijuana plant material.87 Cultivators must submit each 
batch of marijuana to testing laboratories, and then processors are also 
obliged to submit a random sample from every lot of marijuana to 
testing laboratories.88 Before a processor may sell any marijuana 
product to a dispensary, the processor must first send information about 
each product to the Ohio Board of Pharmacy (BOP) for approval.89 
The BOP reviews identifying product information and determines if the 
marijuana product contains a permissible amount of THC under Ohio 
law.90 If the product is marijuana plant material, then the THC content 
must be 35% or less.91 If the product is an extract, then the THC 
content must be 70% or less.92 BOP issuance of a product identifier for 
the marijuana product signifies that the marijuana product has a 
permissible amount of THC.93 Any dose of a medical marijuana product 
to be sold by a dispensary must not have more than fifty milligrams of 
THC, and each dose must contain a concentration of THC, THCA, 
CBD, and CBDA within 95% to 105% of the concentration indicated 
on the product label.94 
After manufacture and BOP approval, processors package and label 
the medical marijuana product or plant for distribution to a dispensary 
in a package approved by the Ohio Department of Commerce.95 On the 
label for medical marijuana plant material, the processor must include 
the name of the strain of plant material that is registered with the Ohio 
Department of Commerce.96 On the label for a medical marijuana 
product, the processor must include the registered name of the 
originating strain, the form, and the dose.97 On all forms of medical 
 
87. See Ohio Admin. Code 3796:2-2-01, 3796:2-2-02 (2019) (establishing 
minimum requirements for cultivator operations). 
88. Ohio Admin. Code 3796:3-2-06 (2019). 
89. Ohio Admin. Code 3796:8-2-05 (2019). 
90. Ohio Admin. Code 3796:8-2-05(C) (2019). 
91. Ohio Rev. Code § 3796.06(D)(1) (2019). 
92. Id. § 3796.06(D)(2). 
93. Ohio Admin. Code 3796:8-2-05(C) (2019); Ohio Rev. Code § 3796.06 
(2019). 
94. Ohio Admin. Code 3796:8-2-06(B)–(D) (2019). 
95. Ohio Admin. Code 3796:3-2-02(A) (2019). 
96. Ohio Admin. Code 3796:3-2-02(A)(2)(d) (2019). 
97. Id. 
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marijuana packaged for dispensaries, the processors must include the 
cannabinoid profile from the testing laboratory; the dates of manu–
facture, final testing, packaging, and future expiration; the licenses of 
the cultivator and processor; and the following statement: “This 
product is for medical use and not for resale or transfer to another 
person. This product may cause impairment and may be habit-forming. 
This product may be unlawful outside the State of Ohio.”98 If the 
marijuana product is edible, the processor must also write, “Caution: 
When eaten or swallowed, the effects and impairment caused by this 
drug may be delayed.”99 
Medical marijuana dispensaries are the entities that ultimately 
place medical marijuana products in the hands of approved patients or 
their caregivers. Ohio requires that all medical marijuana sales must be 
in a face-to-face meeting with a dispensary employee and the patients 
or caregiver.100 Dispensaries are responsible to communicate information 
about the specific product and medical marijuana generally via product 
labels,101 accompanying printed material with the product,102 and a 
“patient and caregiver education and support policy.”103 Each product 
label must include the cannabinoid profile and concentration levels of 
THC as determined by the testing laboratory and the same warning 
that states: “Caution: When eaten or swallowed, the effects and 
impairment caused by this drug may be delayed.”104 The accompanying 
printed material must also include a warning that states: “Marijuana 
can impair concentration, coordination and judgment. Do not operate 
a vehicle or machinery under the influence of this drug.”105 
A dispensary’s policy must educate patients and caregivers about 
medical marijuana.106 Ohio requires the policies to include information 
about the “purported effectiveness” of medical marijuana; signs of 
substance abuse and dependency; the illegal status of marijuana under 
federal law; possible interactions with other drugs including alcohol; 
and “[i]nformation about possible side effects and contraindications for 
 
98. Ohio Admin. Code 3796:3-2-02(A)(2)(m) (2019) (emphasis added). The 
specific “cannabinoid profile” includes the percentage by weight or total 
milligrams per unit for THC, THCA, CBD and CBDA. Ohio Admin. 
Code 3796:3-2-02(A)(2)(i) (2019). 
99. Ohio Admin. Code 3796:3-2-02(A)(2)(k)(iii) (2019) (emphasis added). 
100. Ohio Admin. Code 3796:6-3-08(I) (2019). 
101. Ohio Admin. Code 3796:6-3-09(A) (2019). 
102. Ohio Admin. Code 3796:6-3-09(C) (2019). 
103. Ohio Admin. Code 3796:6-3-15 (2019). 
104. Ohio Admin. Code 3796:6-3-09(A)(10)(c) (2019) (emphasis added). 
105. Ohio Admin. Code 3796:6-3-09(C)(5) (2019) (emphasis added). 
106. See Ohio Admin. Code § 3796:6-3-15. 
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medical marijuana including possible impairment with use and 
operation of a motor vehicle or heavy machinery . . . .”107 
Ohio also requires that dispensaries “make available information to 
patients and caregivers regarding the possession and use of marijuana,” 
including “[l]imitations on the right to possess and use marijuana” in 
Ohio law.108 One such limitation is that the medical marijuana program 
passed by the Ohio legislature “does not authorize a registered patient 
to operate a vehicle, streetcar, trackless trolley, watercraft, or aircraft 
while under the influence of medical marijuana.”109 But the legislation 
also cautions: 
Notwithstanding any conflicting provision of the Revised Code, a 
person’s status as a registered patient or caregiver is not a 
sufficient basis for conducting a field sobriety test on the person 
or for suspending the person’s driver’s license. To conduct any 
field sobriety test, a law enforcement officer must have an 
independent, factual basis giving reasonable suspicion that the 
person is operating a vehicle under the influence of marijuana or 
with a prohibited concentration of marijuana in the person’s 
whole blood, blood serum, plasma, breath, or urine.110 
If a patient operates a “vehicle, streetcar, trackless trolley, 
watercraft, or aircraft while under the influence of medical marijuana,” 
then the BOP may sanction the patient by revoking, suspending, or 
restricting the patient’s status as a medical marijuana patient.111 Dis–
pensaries are the party charged with “mak[ing] available information” 
about the risks of driving under the influence of medical marijuana.112 
IV. Ohio’s Medical Marijuana Patients’                
Risks When Driving 
Medical marijuana patients are deciding, either uninformed or 
informed, to accept great risks each time they decide to drive. These 
risks include the risk to their safety, their risk to their status as a 
patient in the OMMCP, and even their risk to exposure to criminal 
liability. Their driving skills may be impaired, threatening a higher 
likelihood of a car accident. Their driving skills may not be impaired, 
but they may nevertheless lose their status as a medical marijuana 
 
107. Ohio Admin. Code 3796:6-3-15(B)(2), (5) (2019). 
108. Ohio Admin. Code 3796:6-3-15(C) (2019). 
109. Ohio Rev. Code § 3796.22(D) (2019). 
110. Id. § 3796.24(E). 
111. Ohio Admin. Code 3796:7-2-08 (2019). 
112. Ohio Admin. Code 3796:6-3-15(C) (2019). 
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patient and face criminal penalties if suspected of being under the 
influence by a police officer and tested for marijuana in their bodily 
system. 
A. Actual Impairment from Medical Marijuana 
Is it possible for daily consumers of medical marijuana to feel 
confident in their ability to drive safely? There is not a recommended 
timeline for medical marijuana patients to follow between the time of 
consumption and time when it is safe to drive, and the safest advice is 
not to drive at all.113 Any formula for when it may be safe for patients 
to drive is difficult to calculate, as experts agree that the effects of 
marijuana are individualized and vary according to every individual’s 
tolerance, method of consumption, and absorption of the marijuana 
product,114 as well as the nature and potency of the medical marijuana 
product consumed.115 Therefore, the question of when, or if, it is safe 
for a medical marijuana patient to drive must be an individualized 
inquiry. 
It is legally appropriate for patients driving while actually impaired 
by marijuana to face criminal penalties and suspension of their medical 
marijuana license. Those who drive unsafely as a result of a psycho–
active drug are the drivers whom traffic safety laws should penalize.116 
While medical marijuana is not an illegal substance for a medical 
marijuana patient, the legal status of patients’ use is not a mitigating 
factor.117 Regarding a patient’s medical marijuana license, a patient who 
cannot safely benefit from medical marijuana without placing themself 
 
113. Ryan Felton, More than Half of Medical Marijuana Users in a Study Drove 
While High, Consumer Reps. (Jan. 9, 2019), https://www.consumer 
reports.org/marijuana/more-than-half-of-medical-marijuana-users-in-a-stu 
dy-drove-while-high/ [https://perma.cc/YL88-VUYB]. 
114. See Sewell et al., supra note 16, at 190. 
115. Felton, supra note 113. 
116. For example, “driving under the influence of cannabis indicated by self-
report or the presence of THC in bodily fluid is associated with significantly 
higher odds of [a motor vehicle collision].” Ebbert et al., supra note 5, at 
1846. 
117. Ohio OVI law does not criminalize drivers testing positive for an illegal level 
of a controlled substance in their bodily fluids when drivers’ use is pursuant 
to “a prescription issued by a licensed health professional authorized to 
prescribe drugs” and the use is “in accordance with the health professional’s 
directions.” Ohio Rev. Code § 4511.19(K) (2019) (emphasis added). 
Medical marijuana does not fall into this prescription category because 
medical marijuana is not prescribed by a licensed health care professional; 
rather, licensed health care professionals recommend patients to the 
OMMCP. Joseph Gregorio, Physicians, Medical Marijuana, and the Law, 
16 Virtual Mentor 732, 733 (2014). 
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and others in harm’s way should not have the privilege to continue 
medical marijuana use without accepting the risk of impairment. 
B. Unimpaired from Medical Marijuana, But Testing                    
Positive for Marijuana 
On the other hand, those medical marijuana patients who are 
capable of consuming marijuana without experiencing impairment—
possibly because of self-awareness, timing, potency, absorption, or 
tolerance—should not suffer consequences for driving only because 
there is detectable marijuana in their bodily systems. As earlier ex–
plained, even if a driver tests positive for a punishable level of marijuana 
in their blood or urine, science does not support the conclusion that a 
particular level of marijuana in a person’s body causes impairment.118 
Also as opined above, Ohio’s per se law for driving under the influence 
of marijuana is scientifically invalid because it punishes drivers for an 
amount of marijuana in their bodies that does not correlate with actual 
impairment. 
Ohio’s medical marijuana patients may violate the law whenever 
driving, not because they are impaired, but merely by consuming their 
medical marijuana as instructed by their physician and distributor.119 
A patient consuming medical marijuana daily may always test positive 
for a criminal amount of marijuana in urine or blood while nevertheless 
driving unimpaired by marijuana.120 Similarly, a patient consuming 
medical marijuana sparingly may test positive for a criminal amount of 
marijuana while driving unimpaired because detectable amounts may 
remain for days to weeks after consumption.121 
Under the current Ohio laws for operating a vehicle while under the 
influence of marijuana, a patient in the OMMCP should not drive if 
the patient values continued status as a medical marijuana patient and 
 
118. Wallace, supra note 48. 
119. See McWaters, supra note 38, at 59 (footnote omitted) (“Chronic and 
medical users can maintain levels of 10 ng/mL several hours after 
consumption, far above the 2 ng/mL and 5 ng/mL levels established by 
various states. Prosecuting these individuals as dangerous when they are 
not legitimately impaired represents a denial of justice and enforcing these 
standards that criminalize impaired as well as non-impaired drivers is 
irresponsible.”). 
120. See id.; see also Ohio Admin. Code 3796:8-2-04(A) (2019) (regulating the 
amount of plant material or THC content authorized to be purchased in a 
single day). 
121. Dan Wagener, How Long Does Pot Stay in Your System?, Am. Addiction 
Ctrs., https://americanaddictioncenters.org/marijuana-rehab/how-long-
system-body [https://perma.cc/64C3-8WPB] (last updated April 5, 2021) 
(“Typically, THC is detectable for up to 90 days in hair, anywhere between 
3 days to a month or longer in urine (depending on how often the person 
uses), up to 48 hours in saliva, and up to 36 hours in blood.”). 
Case Western Reserve Law Review·Volume 71·Issue 4·2021 
Ohio Medical Marijuana Patients and Risks Behind the Steering Wheel 
1367 
fears criminal penalties. Ohio law relating to the OMMCP expressly 
prohibits medical marijuana patients from driving while “under the 
influence” of marijuana,122 but Ohio law for operating a vehicle while 
under the influence of marijuana captures all drivers testing positive for 
the specified amounts of marijuana detected in drivers’ urine or blood.123 
Therefore, Ohio law criminalizes medical marijuana patients if they 
drive—not because of actual impairment, but because patients follow–
ing daily medication instructions from their physicians and dispensaries 
may test positive for the prohibited level of marijuana in their bodies. 
Reading the OMMCP laws in conjunction with the Ohio marijuana 
OVI law leads to the conclusion that medical marijuana patients cannot 
legally drive.124 
V. How Ohio Can Improve 
The message is confusing: Ohio established that marijuana is safe 
enough for use as a medicine, but Ohio does not know enough about 
marijuana to accurately capture whether a person is impaired by 
marijuana or not. There are five ways Ohio can better protect its 
citizens while continuing the medical marijuana program. First, the 
Ohio General Assembly should consider amending the per se under-the-
influence-of-marijuana law to a permissible-inference law. Second, law 
enforcement should continue to increase training of drug recognition 
experts. Third, the OMMCP should provide targeted information about 
the risks of impaired driving for physicians choosing to recommend 
patients for the OMMCP. Fourth, the Ohio Department of Transpor–
tation should invest in public education about the safety and criminal 
risk of driving while impaired by marijuana. And lastly, but perhaps 
most importantly, participants in the OMMCP, especially private 
interest groups, need to support research and innovation related to 
testing for marijuana impairment. 
A. Legal Reform 
States should enforce laws that are at least scientifically valid. In 
the absence of a scientifically approved method for testing marijuana  
122. Ohio Admin. Code 3796:6-3-09(C)(5) (2019). 
123. See Ohio Rev. Code § 4511.19(A)(1)(j)(vii) (2019). 
124. Of course, an officer must have an independent and reasonable basis in fact 
to believe that a driver is impaired, but once an officer passes this threshold, 
a positive test for marijuana beyond the established limits is a criminal 
violation. Defense attorneys in Ohio can challenge a marijuana OVI by 
attacking the actions, reasonable suspicions, and probable cause of the 
officer who ordered the bodily fluid test. See Ohio Marijuana/THC OVIs, 
Law Offs. of Brian J. Smith, Ltd., https://www.briansmithlaw.com/ 
ohio-marijuana-thc-ovi [https://perma.cc/B6K9-35CF] (last visited Mar. 
17, 2019). 
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impairment, states’ standards for driving while under the influence of 
marijuana vary.125 The National Conference of State Legislatures 
divides the state laws into four main categories: zero-tolerance laws, per 
se laws, under-the-influence laws, and permissible-inference laws.126 In 
states with zero-tolerance laws, a driver who tests positive for any 
amount of marijuana is violating state law.127 States with per se laws, 
like Ohio, establish limits for the amount of marijuana that can be 
detectable in a driver, and a driver with test results that exceed the 
established limit violates state law.128 Under-the-influence laws require 
that the state prove a driver was affected by THC while driving.129 
Lastly, Colorado is the only state with a permissible-inference law. 
There, if a driver tests positive for a certain amount of marijuana, then 
it is permissible for a factfinder to draw to the conclusion that the driver 
was under the influence of marijuana.130 
Colorado’s permissible-inference law is more scientifically valid, 
especially for medical marijuana patients, than Ohio’s per se law. In 
Ohio, testing positive for 2 ng/mL of marijuana will almost certainly 
result in a DUI charge.131 In Colorado, testing positive for 5 ng/mL of 
THC in blood allows for a DUI conviction, but state authorities or the 
factfinder may allocate more weight to other facts and decide to not 
charge or convict a driver testing positive.132 Consider the following 
hypothetical as an example of how a permissible-inference law is a 
superior law to a per se law in the absence of a proven correlation 
between the amount of THC in a person’s body and the person’s level 
of impairment. 
Your responsible friend suffers from multiple sclerosis. Her doctors 
treated her muscle spasticity, which is painful tightening and stiffening 
of muscles, with medical marijuana as a last resort. Her doctors 
recommended her for the OMMCP, and she and an employee at her 
nearest medical marijuana dispensary discussed at length how she 
should orally consume a THC oil product. She read the label on the 
product when the employee gave her the oil: “Caution: When eaten or 
swallowed, the effects and impairment caused by this drug may be 
 
125. Drugged Driving: Marijuana-Impaired Driving, supra note 20. 
126. Id. 
127. For states with medical marijuana programs, a zero-tolerance law creates a 




131. See, e.g., Ohio Marijuana/THC OVIs, supra note 124. 
132. See Drugged Driving: Marijuana-Impaired Driving, supra note 20. 
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delayed.”133 The employee bagged the oil for her, and in her car, she 
saw a printed document included in the bag. It warned, “Marijuana can 
impair concentration, coordination and judgment. Do not operate a 
vehicle or machinery under the influence of this drug.”134 
Your friend discussed her new medical marijuana with her family, 
and she expressed concern about whether she would feel impaired by 
the oil. A few of her family members also read the product label and 
the printed document found in the bag. She decided that she should 
begin using the THC oil immediately because her muscle spasticity 
continued to worsen, and a family member agreed to drive her to work 
for the rest of the week in case she felt strange on the new medication. 
She placed a drop of THC oil under her tongue twice a day, once at six 
o’clock in the morning and again at ten o’clock in the evening. Each 
drop contained approximately fifty milligrams of THC. 
After a few weeks of relying on others to drive her, she realized that 
she actually felt comfortable and in control of herself while consuming 
daily doses of medical marijuana. She began to drive herself to work, 
and she drove without flaw for one year. 
One day while driving home from a new restaurant around nine 
o’clock at night, she did not see a stop sign. A police officer pulled her 
over for running through the intersection. She apologized with startled 
eyes, and her hands fumbled around her glove compartment to find her 
registration. She began crying in frustration, and her eyes were 
bloodshot when she finally turned towards the officer with her license 
and registration. Upon viewing her bloodshot eyes after her moment of 
panic, the officer asked her if she recently consumed drugs or alcohol. 
She answered in the negative. Nevertheless, the officer insisted that she 
ride in the officer’s vehicle and complete a blood test for drugs. 
Your friend’s blood tested positive for 7 ng/mL of THC. In Ohio, 
your friend is likely charged and convicted.135 After one year of safe 
driving and not showing any signs of impairment while driving with 
friends in her car, she is convicted for driving under the influence of 
marijuana. 
Colorado, on the other hand, may or may not convict your friend. 
The factfinder could convict her because of the 7 ng/mL of THC in her 
blood, but the law does not require the factfinder to convict her. The 
factfinder could listen to her testimony about initially waiting to drive 
until she felt comfortable medicating with the THC oil; her friends’ 
testimony about her unimpaired driving; the arresting officer’s test–
imony that he only saw her red eyes after she began crying; and an 
 
133. Ohio Admin. Code 3796:6-3-09(A)(10)(c) (2019). 
134. Ohio Admin. Code 3796:6-3-09(C)(5) (2019). 
135. See Ohio Marijuana/THC OVIs, supra note 124 (pointing out the 
possibility of being charged with an OVI despite not feeling impaired, if an 
individual tests over the State’s limit for THC). 
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expert’s testimony that missing a stop sign is not a typical driving error 
for drivers impaired by marijuana. Colorado courts can consider that 
your friend was not impaired by marijuana while driving and that she 
made a driving error that a perfectly sober driver could make. The 
Colorado court does not convict your friend just because she has THC 
from her medical marijuana, that she most recently administered fifteen 
hours earlier, in her blood. 
Ohio needs to take seriously the THC levels that patients in the 
state’s own medical marijuana program will maintain whenever driving 
and amend the marijuana OVI law to reflect that testing positive 
for 5 ng/mL or more THC in a patient’s blood does not mean that the 
patient is impaired by the state-approved medical marijuana. A 
permissible-inference law is one viable solution. 
B. Drug Recognition Expert Training 
Before testing for drug intoxication, an officer must first have a 
reasonable basis in sufficient facts that the driver is likely under the 
influence of a drug.136 Therefore, if an officer does not suspect that a 
driver is under the influence of drugs, the officer cannot order a blood 
or urine test.137 Ohio should continue to offer “Drug Recognition 
Expert” training to officers.138 Medical marijuana patients will have less 
risk of testing positive for an illegal amount of marijuana in their bodies 
without being actually impaired if more officers are skilled in detecting 
actual impairment. 
C. Physicians 
Physicians play the central role in educating patients about the 
benefits and risks of particular medicines. Ohio established a separate 
standard of care for physicians recommending patients for the 
OMMCP.139 The physician is required to inform the patient about “the 
risks and benefits of treatment with medical marijuana as it pertains to 
the patients [sic] qualifying medical condition and medical history.”140 
The American Medical Association and the Mayo Clinic believe 
 
136. Lewis R. Katz, Ohio Arrest, Search and Seizure §18:17 (2019 ed.). 
137. Id. 
138. See Brian Duffy, Drug Recognition Experts Climbing in Northeast Ohio to 
Combat Drugged Driving, 19 News (Aug. 22, 2018, 3:16 AM), 
https://www.cleveland19.com/story/38933913/drug-recognition-experts-cli 
mbing-in-northeast-ohio-to-combat-drugged-driving/ [https://perma.cc/6 
WW3-MESE]; see also The Ohio Drug Recognition Expert Program 
Application Information, Ohio Highway Safety Off., https://ohiohigh 
waysafetyoffice.ohio.gov/doc/DRE_Application.pdf [https://perma.cc/FA 
9A-HWD7] (last visited May 25, 2021). 
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physicians should also be capable of counseling patients about the 
dangers of impaired driving and motor vehicle accidents caused by 
medical marijuana.141 If Ohio physicians warn patients about the 
adverse effects marijuana may have on patients’ driving, then patients 
could make well-informed decisions about whether the benefits of 
medical marijuana are worth the risks to them. 
D. Public Education 
As instances of driving under the influence of marijuana increase, 
Ohio needs to educate the public that the state enterprise for marijuana 
use as a medicine does not mean that medical marijuana is without 
psychoactive and unsafe consequences.142 National Highway Traffic 
Safety Administration statistics, as well as state statistics, indicate a 
growing prevalence of individuals consuming marijuana and then 
getting behind the wheel.143 Nationally, drivers testing positive for THC 
increased by 48% from 2007 to 2014.144 In states with licensed medical 
marijuana dispensaries, there is a 14% increase in individuals driving 
under the influence of marijuana compared to states without licensed 
medical marijuana dispensaries.145 
A significant population of medical marijuana patients drive while 
in an unsafe mental state. Researchers in Michigan shared concern 
about the percent and frequency of medical marijuana chronic pain 
patients driving soon after consuming marijuana.146 Surveying a six-
month period, a majority of Michigan patients surveyed disclosed that 
they drove within two hours of consuming marijuana, half disclosed 
driving while feeling “a little high,” and 21.1% disclosed driving while 
feeling “very high.”147 When surveyed about their driving behavior in 
the same six-month time period, 21.6% of patients drove ten or more 
times within two hours of consuming marijuana, 18.7% of patients 
 
141. See Ebbert et al., supra note 5, at 1846; see also AMA Report, supra note 
11, at 11. 
142. It’s Legal in Many States, so Doesn’t that Mean Marijuana is Safe?, Ctrs. 
for Disease Control & Prevention, https://www.cdc.gov/marijuana/ 
faqs/is-marijuana-safe-because-its-legal.html [https://perma.cc/2VC8-58L 
R] (last visited Mar. 7, 2021). 
143. NHTSA Report, supra note 2, at 20–21. 
144. Id. at 20–21. 
145. Sevigny, supra note 70, at 61. 
146. Erin E. Bonar, James A. Cranford, Brooke J. Arterberry, Maureen A. 
Walton, Kipling M. Bohnert & Mark A. Ilgen, Driving Under the Influence 
of Cannabis Among Medical Cannabis Patients with Chronic Pain, 195 
Drug and Alcohol Dependence 193, 195–96 (2019). 
147. Id. at 194. 
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drove ten or more times while feeling “a little high,” and 7.2% of 
patients drove ten or more times while feeling “very high.”148 
Similarly, in Colorado a majority of marijuana consumers have 
driven within two hours of consuming marijuana, and the frequency of 
driving within two hours of consumption increased from 10% in 2014 
to 21% in 2016.149 Some blame the increase in driving under the 
influence of marijuana on the perception that marijuana is safe, or at 
least safer than alcohol.150 With the increased frequency of drivers 
operating under the influence of marijuana in Colorado, there is a 
corresponding increase in marijuana-related motor vehicle deaths. 
Within three years of Colorado’s recreational marijuana program, there 
was a 48% increase in motor vehicle fatalities related to marijuana.151 
The increase in Washington was even more dramatic: the presence of 
THC in the deceased drivers’ blood increased by 120% from 2010 to 
2014.152 
In light of the studies from other states, Ohio should begin to take 
notice of any increases in incidents of driving under the influence of 
marijuana since the OMMCP began. The Colorado Department of 
Transportation is taking notice of the increased incidents and spending 
almost one million dollars in an education effort to deter driving while 
under the influence of marijuana.153 Ohio has a responsibility to educate 
the public that driving while under the influence of marijuana is 
dangerous and illegal, whether the driver used legal medical marijuana 
or illegal recreational marijuana. 
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E. Research 
Ohio and private interest groups need to invest in research and 
development for medical marijuana and roadway safety. While the FDA 
“supports” state research to develop safe and effective marijuana 
products,154 Congress placed a general prohibition on federal agencies 
and states using federal funds for marijuana research.155 Marijuana is 
still illegal under federal law.156 Although a majority of states permit 
marijuana use through state medical marijuana programs,157 the federal 
government categorizes marijuana as an illegal substance with “a high 
potential for abuse;” “no currently accepted medical use in treatment 
in the United States;” and “a lack of accepted safety for use of the drug 
or other substance under medical supervision.”158 This Note is not about 
the conflict between the current federal and state laws, but for the 
purposes of this Note, it is important to know that the illegal status of 
marijuana is a large barrier to marijuana research. 
States and private parties are nevertheless engaging in necessary 
research for medical marijuana. The NHTSA recommends that state 
law enforcement agencies at least collect data from incidents of 
marijuana use by drivers.159 Additionally, the NHTSA implores resear–
chers to develop a workable standard of impairment.160 If Ohio is 
charging drivers for impairment caused by marijuana because of a level 
of detectable marijuana in their bodies, Ohio ought to have a valid basis 
in science to criminalize that level of detectable marijuana, and Ohio 
can only discover a valid basis in science through research. 
Conclusion 
Medical marijuana patients are ultimately responsible for their own 
behavior. But patients cannot drive responsibly unless they know when 
they are unimpaired, and they cannot drive without risk of jeopardizing 
their OMMCP patient status and facing criminal penalties unless the 
marijuana OVI law reflects actual impairment. A difficult consequence 
to accept if deciding to use medical marijuana may be to no longer drive 
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because there is not even a concrete medical recommendation for how 
long a patient can wait after consuming a medical marijuana product 
before any symptoms of impairment diminish.161 The entities involved 
in the OMMCP need to take responsibility for educating patients about 
the safety, medical, and legal risks patients must accept if using medical 
marijuana. Finally, the Ohio General Assembly must amend the 
marijuana OVI law to capture impaired drivers more accurately instead 




161. See Ebbert et al., supra note 5, at 1846. 
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